The Kidney Outcomes Prediction and Evaluation (KOPE) study: A prospective cohort investigation of patients undergoing hemodialysis: Study design and baseline characteristics

Annals of Epidemiology

Volumn 8, Issue 3, 1998, Pages 192-200

  Sevick, Mary Ann ^a,b   Tell, Grethe S ^a,b   Shumaker, Sally A ^a,b   Rocco, Michael V ^a,b   Burkart, John M ^a,b   Rushing, Julia T ^a,b   Levine, Doug W ^a,b   Chen, G John ^a,b   Bradham, Douglas D ^a,b   Pierce, June J ^a,b   James, Margaret K ^a,b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Chronic Renal Failure; Hemodialysis; Morbidity; Mortality; Quality of Life; Renal Replacement Therapy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CAUCASIAN; CHRONIC KIDNEY FAILURE; COHORT ANALYSIS; FEMALE; HEMODIALYSIS; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEGRO; OBSERVATION; OUTCOMES RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RACE DIFFERENCE; SEX DIFFERENCE; SOCIAL ASPECT;

ADULT; AGED; COHORT STUDIES; DEMOGRAPHY; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MENTAL HEALTH; MIDDLE AGED; MORBIDITY; NORTH CAROLINA; OUTCOME ASSESSMENT (HEALTH CARE); PREVENTIVE MEDICINE; PROSPECTIVE STUDIES; QUALITY OF LIFE; REFERENCE VALUES; RENAL DIALYSIS; RESEARCH DESIGN; SOCIAL SUPPORT;

EID: 0032053743     PISSN: 10472797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1047-2797(97)00175-0     Document Type: Article

References (52)

1. United States Renal Data Systems: USRDS 1997 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD; 1997.
2. Port FK End-stage renal disease. Magnitude of the problem, prognosis of future trends and possible solutions Kidney Internat. (Suppl). 50:1995;S3-S6.
3. Agoda LY, Jones CA, Held PJ End-stage renal disease in the USA. Data from the United States Renal Data System Am J Nephrol. 16:1996;7-16.
4. Owen W, Lew N, Liu Y, Lowrie E, Lazarus J The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Eng J Med. 329:1993;1001-1006.
5. Collins AJ, Ma JZ, Umen A, Keshaviah P Urea index and other predictors of long-term outcome in hemodialysis patient survival. Am J Kidney Dis. 23:1994;272-282.
6. Hakim R, Breyer J, Ismail N, Schulman G Effects of dose of dialysis on morbidity and mortality. Am J Kidney Dis. 23:1994;661-669.
7. Parker T, Husni L, Huang W, Lew N, Lowrie E Survival of hemodialysis patients in the United States is improved with a greater quantity of dialysis. Am J Kidney Dis. 23:1994;670-680.
8. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: An NIH Consensus Conference statement. Ann Int Med. 1994;121:62-70.
9. Christensen AJ, Benotsch EG, Wiebe JS, Lawton WJ Coping with treatment-related stress. Effects on patient adherence in hemodialysis J Consult Clin Psychol. 63:1995;454-459.
10. Christensen AJ, Smith TW Personality and patient adherence. correlates of the five-factor model in renal dialysis J Behav Med. 18:1995;305-313.
11. Christensen AJ, Smith TW, Turner CW, Cundick KE Patient adherence and adjustment in renal dialysis. A person x treatment interactive approach J Behav Med. 17:1994;549-566.
12. Morduchowicz G, Sulkes J, Aizic S, Gabbay U, Winkler J, Boner G Compliance in hemodialysis patients. A multiple regression analysis Nephron. 64:1993;365-368.
13. Hitchcock PB, Brantley PJ, Jones GN, McKnight GT Stress and social support as predictors of dietary compliance in hemodialysis patients. Behav Med. 18:1992;13-20.
14. Schneider B Multidimensional health locus of control as partial predictor of serum phosphorus in chronic hemodialysis. Psychol Rep. 70:1992;1171-1174.
15. Christensen AJ, Smith TW, Turner CW, Holman JM Jr., Gregory MC, Rich MA Family support, physical impairment, and adherence in hemodialysis. an investigation of main and buffering effects J Behav Med. 15:1992;313-325.
16. Schneider MS, Friend R, Whitaker P, Wadhwa NK Fluid noncompliance and symptomatology in end-stage renal disease. Cognitive and emotional variables Health Psychol. 10:1991;209-215.
17. Tell GS, Mittelmark MB, Hylander B, Shumaker SA, Russell G, Burkart JM Social support and health-related quality of life in black and white dialysis patients. ANNA J. 22:1995;301-308.
18. Evans RW, Manninen DL, Garrison LP, Hart LG, Blagg CR, Gutman RAet al. The quality of life of patients with end-stage renal disease. N Eng J Med. 312:1985;553-559.
19. Ferrans CE, Powers MJ Quality of life of hemodialysis patients. ANNA J. 20:1993;575-581.
20. Oldenburg B, MacDonald GJ, Perkins RJ Prediction of quality of life in a cohort of end-state renal disease patients. J Clin Epidemiol. 41:1988;555-564.
21. Johnson JP, McCauley CR, Copley JB The quality of life of hemodialysis and transplant patients. Kidney Internat. 22:1982;286-291.
22. Julius M, Hawthorne VM, Carpentier-Alting P, Kneisley J, Wolfe RA, Port FK Independence in activities of daily living for end-stage renal disease patients. Biomedical and demographic correlates Am J Kidney Dis. 13:1989;61-69.
23. Nolph KD Why are reported mortality risks for CAPD and HD so variable? (Inadequacies of the Cox Proportional Hazards Model). Peritoneal Dialysis International. 16:1996;15-18.
24. Rocco MV, Soucie JM, Reboussin DM, McClellan WM Risk factors for hospital utilization in chronic dialysis patients. J Am Soc Nephrol. 7:1996;889-896.
25. Farias MG, Soucie JM, McClellan W, Mitch WE Race and risk of peritonitis. An analysis of factors associated with the initial episode Kidney Internat. 46:1996;1392-1396.
26. McClellan W, Soucie JM Facility mortality rates for new end-stage renal disease patients. Implications for quality improvement Am J Kidney Dis. 24:1994;280-289.
27. Soucie JM, Neylan JF, McClellan W Race and sex differences in the identification of candidates for renal transplantion. Am J Kidney Dis. 19:1992;414-419.
28. Basile C, Casino F, Lopez T Percent reduction in blood urea concentration during dialysis estimates Kt/V in a simple and accurate way. Am J Kidney Dis. 15:1990;40-45.
29. Blagg CR, Liedtke RJ, Batjer JD, Racoosin B, Sawyer TK, Wick MJet al. Serum albumin concentration-related health care financing administration quality assurance criterion is method-dependent. Revision is necessary Am J Kidney Dis. 21:1993;138-144.
30. Joseph R, Tria L, Mossey RT, Bellucci AG, Mailloux LU, Vernace MAet al. Comparison of methods for measuring albumin in peritoneal and hemodialysis patients. American J Kidney Dis. 27:1996;566-572.
31. Hays RD, Sherbourne CD, Mazel RM The RAND 36-item health survey 1.0. Health Econ. 2:1993;217-227.
32. Karnofsky DA, Burchena JH The Clinical Evaluation of Chemotherapeutic Agents in Cancer. MacLeod CM Evaluation of Chemotherapeutic Agents. 1949;Columbia Press, New York.
33. Rejeski WJ, Ettinger WH, Shumaker S, James P, Burns R, Elam JT Assessing performance-related disability in patients with knee osteoarthritis. Osteoarthr Cartil. 3:1995;157-167.
34. Ware JE, Snow KK, Kosinski M, Gandek B SF-36 Health Survey Manual and Interpretation Guide. 1993;The Health Institute, New England Medical Center, Boston.
35. Sherbourne CD, Stewart AL The MOS Social Support Survey. Soc Sci Med. 32:1991;705-714.
36. Berkman LF Alameda social integration. Am J Epidemiol. 123:1986;559-562.
37. Melzack R The Short-Form McGill Pain Questionnaire. Pain. 30:1987;191-197.
38. Melzack R The McGill Pain Questionnaire. Major properties and scoring methods Pain. 1:1975;227-299.
39. Scheier MF, Carver CS Optimism, coping, and health; Assessment and implications of generalized outcome expectancies. Health Psychol. 4:1985;219-247.
40. Speilberger CD, Gorsuch RL, Lushene RE STAI Manual for the State-Trait Anxiety Inventory (Self-Evaluation Questionnaire). 1970;Consulting Psychologists Press, Palo Alto.
41. Radloff LS The CES-d scale. A self-report depression scale for research in the general population Applied Psychol Meas. 3:1977;385-401.
42. Burman MA, Wells KB, Leake B, Landsverk J Development of a brief screening instrument for detecting depressive disorders. Medical Care. 26:1988;775-789.
43. United States Renal Data System: USRDS 1995 Annual Data Report. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda MD; April 1995.
44. United States Department of Health and Human Services. Highlights from the 1995 ESRD Core Indicators Study for Hemodialysis Patients. Publication 1996-411-875/49120. Government Printing Office; 1996.
45. Lowrie EG, Lew NL Death Risk in Hemodialysis Patients. The Predictive Value of Commonly Measured Variables and an Evaluation of Death Rate Differences Between Facilities Am J Kidney Dis. 5:1990;458-482.
46. U. S. Bureau of the Census. County and City Data Book. Washington, D.C.: US Government Printing Office; 1994;396-410.
47. U. S. Bureau of the Census. Statistical Abstract of the United States. 115th ed. Washington, DC: Government Printing Office; 1994; 19-49.
48. Tell GS, Hylander B, Craven TE, Burkart J Racial differences in the incidence of end-stage renal disease. Ethnicity and Health. 1:1996;21-31.
49. Rocco M, Bleyer A, Burkart J Utilization of inpatient and outpatient resources for the management of hemodialysis access complications. Am J Kidney Dis. 28:1996;250-256.
50. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P Markers for survival in dialysis. A seven-year prospective study Am J Kidney Dis. 26:1995;209-219.
51. Ferguson R, Morrissey E Risk factors for end-stage renal disease among minorities. Transpl Proc. 25:1993;2415-2420.
52. Lopes AA, Port FK Differences in the patterns of age-specific black/white comparisons between end-stage renal disease attributed and not attributed to diabetes. Am J Kidney Dis. 25:1995;714-721.